Cargando…
Serological muscle loss biomarkers: an overview of current concepts and future possibilities
BACKGROUND: The skeletal muscle mass is the largest organ in the healthy body, comprising 30–40 % of the body weight of an adult man. It confers protection from trauma, locomotion, ventilation, and it represents a “sink” in glucose metabolism and a reservoir of amino acids to other tissues such as t...
Autores principales: | Nedergaard, Anders, Karsdal, Morten A., Sun, Shu, Henriksen, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581612/ https://www.ncbi.nlm.nih.gov/pubmed/22996343 http://dx.doi.org/10.1007/s13539-012-0086-2 |
Ejemplares similares
-
Type VI collagen turnover-related peptides—novel serological biomarkers of muscle mass and anabolic response to loading in young men
por: Nedergaard, Anders, et al.
Publicado: (2013) -
Collagen fragment biomarkers as serological biomarkers of lean body mass – a biomarker pilot study from the DAHANCA25B cohort and matched controls
por: Nedergaard, Anders, et al.
Publicado: (2015) -
Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies
por: Arvanitidis, A., et al.
Publicado: (2016) -
A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrest
por: Jonesco, Ditte S., et al.
Publicado: (2019) -
The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer’s disease, other types of dementia and non-demented controls: A cross-sectional study
por: Jonesco, Ditte S., et al.
Publicado: (2020)